Volume 16, Number 5—May 2010
Dispatch
Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA
Table
Characteristic | Levofloxacin | Moxifloxacin | Neither† | Total |
---|---|---|---|---|
No. hospitals | 13 | 8 | 1 | 22 |
No. beds, median (IQR) | 232 (108–371) | 361 (217–565) | 1,008 | 316 (125–424) |
Type of facility | ||||
Tertiary care | 0 | 2 | 1 | 3 |
Acute care | 9 | 6 | 0 | 15 |
Long-term acute care | 4 | 0 | 0 | 4 |
Hospital system | ||||
System 1 | 1 | 5 | 0 | 6 |
System 2 | 11 | 0 | 1 | 12 |
Neither | 1 | 3 | 0 | 4 |
No. cases of C. difficile infection | 494 | 569 | 206 | 1,269 |
Patient-days | 580,893 | 666,719 | 293,833 | 1,541,445 |
Rate of C. difficile infection/10,000 patient-days, median (IQR) | 8.5 (7.8–9.3) | 8.5 (7.8–9.2) | 7.0 (6.1–8.0) | 8.2 (7.8–8.7) |
*IQR, interquartile range.
†Ciprofloxacin on formulary but no respiratory fluoroquinolone on formulary.
Page created: December 23, 2010
Page updated: December 23, 2010
Page reviewed: December 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.